Trinity Biotech PLC (TRIB)
1.52
0.00 (0.00%)
USD |
NASDAQ |
May 15, 15:08
Trinity Biotech Cash and Short Term Investments (Quarterly): 3.691M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.691M |
| September 30, 2023 | 6.261M |
| June 30, 2023 | 14.23M |
| March 31, 2023 | 3.532M |
| December 31, 2022 | 6.578M |
| September 30, 2022 | 7.254M |
| June 30, 2022 | 10.45M |
| March 31, 2022 | 10.01M |
| December 31, 2021 | 25.91M |
| September 30, 2021 | 27.48M |
| June 30, 2021 | 28.62M |
| March 31, 2021 | 32.28M |
| December 31, 2020 | 27.33M |
| September 30, 2020 | 19.91M |
| June 30, 2020 | 15.57M |
| March 31, 2020 | 13.24M |
| December 31, 2019 | 16.40M |
| September 30, 2019 | 25.09M |
| June 30, 2019 | 24.99M |
| March 31, 2019 | 29.43M |
| December 31, 2018 | 30.28M |
| September 30, 2018 | 35.68M |
| June 30, 2018 | 49.43M |
| March 31, 2018 | 53.90M |
| December 31, 2017 | 57.61M |
| Date | Value |
|---|---|
| September 30, 2017 | 62.53M |
| June 30, 2017 | 63.98M |
| March 31, 2017 | 69.85M |
| December 31, 2016 | 77.11M |
| September 30, 2016 | 84.75M |
| June 30, 2016 | 84.92M |
| March 31, 2016 | 96.83M |
| December 31, 2015 | 101.95M |
| September 30, 2015 | 104.29M |
| June 30, 2015 | 110.26M |
| March 31, 2015 | 5.745M |
| December 31, 2014 | 9.102M |
| September 30, 2014 | 8.949M |
| June 30, 2014 | 15.15M |
| March 31, 2014 | 17.01M |
| December 31, 2013 | 22.32M |
| September 30, 2013 | 26.81M |
| June 30, 2013 | 66.16M |
| March 31, 2013 | 73.10M |
| December 31, 2012 | 74.95M |
| September 30, 2012 | 74.46M |
| June 30, 2012 | 73.60M |
| March 31, 2012 | 65.50M |
| December 31, 2011 | 71.08M |
| September 30, 2011 | 71.13M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
3.532M
Minimum
Mar 2023
32.28M
Maximum
Mar 2021
16.78M
Average
15.57M
Median
Jun 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| Amarin Corp PLC | 308.18M |
| Avadel Pharmaceuticals PLC | 88.79M |
| DBV Technologies SA | 101.52M |
| Cellectis SA | 203.82M |
| Adaptimmune Therapeutics PLC | 146.94M |